Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Find out Which Dividend Growth ETF Has Low Fees and what to look for in expense ratios. Get tips to compare funds effectively.
28,299 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Cloudflare surged about 9% in midday trading after a Scotiabank upgrade. The move comes as AI cloud peers like Oracle...
Walmart beat Q4 estimates on earnings and revenue but guided FY27 growth below consensus, sparking bearish chatter fr...
Rambus navigates a cooling memory-chip cycle that could weigh on margins even as AI infrastructure demand remains a k...
Could tesla stock going $1,000? happen? This article weighs the drivers, risks, and a solid plan for investors consid...
Zcash (ZEC) posts a near-90% jump over the last month, bucking broader market weakness. Analysts debate whether this ...
Bitcoin dived to around $59,000, briefly erasing hundreds of billions in value before rebounding. Analysts debate whe...
Ripple’s emeritus CTO outlines a reservation-based fix for XRPL front-running on the DEX/AMM, setting up a high-stake...
When a Berkshire Hathaway leader makes a move with a high-profile name like Amazon, the market takes notice. This pie...
A small-business owner in upstate New York is turning stickers into a political platform, blending merchandise with a...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
Investors are weighing Plug Power's turnaround against hydrogen hype. This guide breaks down the signals, risks, and ...